Diagnosing Drug Allergy: the T is the Key

Launched by UNIVERSITY HOSPITAL, ANTWERP · May 7, 2024

Keywords

ClinConnect Summary

This clinical trial, called "Diagnosing Drug Allergy: the T is the Key," is investigating a new test designed to help diagnose allergies to amoxicillin, a common antibiotic. The test focuses on how certain immune cells respond to the drug. Researchers want to see if this test is reliable and easy to use for people who might be allergic to amoxicillin.

To participate, individuals need to be at least 6 years old and have a suspected history of amoxicillin allergy. They will visit the hospital one to five times, where healthcare providers will collect blood samples and possibly perform skin tests to check for allergies. It’s important to note that pregnant or breastfeeding women are not eligible for this study. If you or your child might have an amoxicillin allergy, this trial could offer a new way to find out for sure.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• Participants are eligible if they:
• • Are ≥ 6 years
• • Are capable of informed consent, or if appropriate, participants have an acceptable individual capable of giving consent on the participant's behalf (e.g. parent or guardian of a child under 18 years of age)
• • Have a suspected history of amoxicillin allergy
• Exclusion Criteria:
• • Patients who are lacking capacity or do not have an acceptable individual capable to provide informed consent
• • Pregnant women
• • Breastfeeding women